Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03024723 · ClinicalTrials.gov registry record
Nasal Continuous Positive Airway Pressure and Airway Patency in Obese Patient
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 32
- Enrollment target
NCT03024723: Completed study, sponsored by Massachusetts General Hospital.
NCT03024723 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03024723 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The mechanism of Upper airway obstruction (UAO) during anesthesia shares many similarities with the upper airway obstruction observed during obstructive sleep apnea (OSA). Nasal continuous positive airway pressure (nCPAP) via nasal mask (NM) can maintain the airway patent with near 100% success in patients with OSA. Obesity is a major risk factors for obstructive sleep apnea and obese patients have a higher prevalence of UAO during anesthesia. The investigators hypotheses that nCPAP should eliminate airway obstruction in obese patients under anesthesia. The investigators propose to test this hypothesis and determine the efficacy of nCPAP on maintaining airway patency in obese patients who require general anesthesia compared with CPAP administering face mask.
Primary Outcome
This group of the subjects will start with nasal mask or face mask CPAP ventilation. The anesthesia care team does whatever they routinely do, including adjusting the patient's position (as to reverse Trendelenburg position), pre-oxygenation, pre-medication, as usual with intravenous anesthetics and analgesics. When the patient is apneic, CPAP ventilation will be initiated with pressure support mode at PIP 25 cmH2O, ventilation rate 10 BPM, PEEP 10 cmH2O and slope 1 second for 1 min. If ventilat
Interventions
- DEVICE nasal mask CPAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-03 |
What the finished NCT03024723 record still lists
NCT03024723 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which nasal mask CPAP is the first listed.
NCT03024723 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03024723 about?
NCT03024723 is a clinical study titled "Nasal Continuous Positive Airway Pressure and Airway Patency in Obese Patient". The mechanism of Upper airway obstruction (UAO) during anesthesia shares many similarities with the upper airway obstruction observed during obstructive sleep apnea (OSA). Nasal continuous positive airway pressure (nCPAP) via nasal mask (NM) can maintain the airway patent with near 100% success in p...
What is the current status of trial NCT03024723?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2015-04. Estimated completion is 2016-03.
What interventions are being tested in trial NCT03024723?
The interventions under investigation include: nasal mask CPAP (DEVICE).
Who is sponsoring clinical trial NCT03024723?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia